SamchunDang Pharm Shares Plunge After Disclosure Warning

Logo of Samchundang Pharmaceutical. SamchunDang Pharm's stock price, which had risen to become the top in market capitalization on the KOSDAQ market, plummeted to its lower limit price just one day after the announcement of a large-scale U.S. licensing agreement. SamchunDang Pharm's stock price also sharply declined as the company received a notice of pre-designation as an unfaithful disclosure…